Announcements
Projects
Orgs
Project Post
Articles 203
Votes 1
0% interested
Neurologylive.com

Authors 99

Marco Meglio
NeurologyLive® Staff
Ralph Nixon
MD
PhD
Matt Hoffman
Yolanda A. Yu
DO
Alon Y. Avidan
MPH
Lynn Bekris
Paul Lipkin
Michael Yeaman
Mirla Avila
Michael Levy
Mitzi Williams
Ashgan Elshinawy
Avindra Nath
Christopher Elder
Gregory A. Rippon
MS
Emma Ciafaloni
Brenda L. Banwell
Sean Pittock
Isabella Ciccone
Joe Kardine
OTR
CBIS
Jessica Ailani
Robert Zivadinov
Dalia Rotstein
Benzi Kluger
Patricia Bobryk
MHS
MSCS
PT
ATP
Darina Petrovsky
RN
James E. Galvin
Nicholas Varvel
Deepti Zutshi
FAAN
Dolores Santamaria
Susan Abushakra
Dawn Edhe
Eli Pollard
M. Shazam Hussain
FRCP(C)
FAHA
Tudor Jovin
Ling Wan-Albert
OTD
Xiang Qi
Bei Wu
Marc Agronin
Stephen Scheinthal
DFACN
DFAPA
CS
Marwan Sabbagh
Sarah C. Stoney
MSW
LSW
Cristina A.F. Román
Brent D. Aulston
Afolasade Fakolade
Leigh Charvet
Douglas Sproule
MSc
Joseph Sullivan
Alistair Mackett
Sharon Fekrat
Mitzi Joi Williams
William Kilgo
Mikael Cohen
Melinda Magyari
Michael Y. Sy
Sharon L. Rogers
Jeffrey Cohen
Sarah Anderson
PharmD
NBC-HWC
Alicyn Magruder
BCACP
Bruce Hughes
Robert Naismith
Adam Mecca
Emad Estemalik
Gregory Krauss
Louis Ferrari
RPh
MBA
Danielle Becker
FAES
Neelam Goyal
Ifrah Zawar
Ponni Subbiah
Martha Morrell
Fosgonimeton's Impact on Neuroprotection and Cognition in Alzheimer Disease - Neurology Live
>1y
Cognitive Benefits in Multiple Sclerosis Seen Through Transcranial Current Stimulation - Neurology Live
>1y
Social Determinants of Health Lead to Greater Suboptimal Treatment Response in Myasthenia Gravis - Neurology Live
>1y
Creatine Kinase Levels Not Considered Risk Factor for COVID-19 Post-Acute Sequelae - Neurology Live
>1y
Treatment Inequality Issues Identified for Patients With Generalized Myasthenia Gravis - Neurology Live
>1y
Impact of High Efficacy Therapies on Understanding of Disease Progression in MS - Neurology Live
>1y
Resources on MS Biosimilars for Patients and Clinicians - Neurology Live
>1y
Updates in the Management of Excessive Daytime Sleepiness and Narcolepsy - Neurology Live
>1y
RAINBOWFISH Results Highlight Risdiplam as Effective Treatment for Presymptomatic SMA - AJMC.com Managed Markets Network
>1y
Remote Exercise and Physiotherapy Programs Show Benefit for Depressive Symptoms in MS - Neurology Live
>1y
The Complexities of Alzheimer Disease Treatment and Diagnosis in Clinical Trials: Sharon L. Rogers, PhD - Neurology Live
>1y
NeuroVoices: Barry Singer, MD, on Recent Strides in the Treatment and Management of Multiple Sclerosis - Neurology Live
>1y
Shifting Toward Precision Care in Multiple Sclerosis Using Disease Activity Tests and Serum Biomarkers: Michael Y. Sy, MD, PhD - Neurology Live
>1y
This Week on NeurologyLive® — October 23, 2023 - Neurology Live
>1y
First-In-Human Trial of Nurr1 Activator HL192 in Parkinson Disease Initiated - Neurology Live
>1y
Phase 1/2 Findings Highlight RGX-202's Safety, Impact on Key Duchenne Biomarkers - AJMC.com Managed Markets Network
>1y
Solanezumab Fails A4 Alzheimer Study, FDA Lifts Hold on FREEDOM-DM1 Trial, CMS Announces Coverages of PET Amyloid-ß Imaging - Neurology Live
>1y
Possibilities of Measuring Cognitive Progression Independent of Relapses in MS: Tom Fuchs, MD, PhD - Neurology Live
>1y
Migraine Medicine in Motion: Jessica Ailani, MD, Discusses CGRP, PACAP, and Patient Selection - Patient Care Online
>1y
Combining Rasagiline With Levodopa and Benserazide Hydrochloride Shows Positive Therapeutic Effects in Mid-Late Parkinson Disease - Neurology Live
>1y
Unpacking the Controversy of Hormone Therapy in Multiple Sclerosis: Melinda Magyari, MD - Neurology Live
>1y
Enhancing Disability Monitoring in Multiple Sclerosis Using Digital Tools: Mikael Cohen, MD - Neurology Live
almost2y
Reviewing the Utilization of Serum Biomarker Tests for Diagnosing Multiple Sclerosis: William Kilgo, MD - Neurology Live
almost2y
Solanezumab Shows No Significant Impact on Preclinical Alzheimer Disease - Neurology Live
almost2y
Advancing Precision Medicine for Multiple Sclerosis: Mitzi Joi Williams, MD - Neurology Live
almost2y